Literature DB >> 1965625

Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake.

J P Leonetti1, G Degols, B Lebleu.   

Abstract

We have previously shown that antisense oligomers linked to poly(L-lysine) (PLL) exhibit antiviral properties against vesicular stomatitis virus (VSV) at concentrations lower than 1 microM. The conjugation to PLL provides an interesting alternative to natural or neutral oligomers to increase the biological effects of antisense oligomers. The internalization pathway of oligomer-PLL conjugates as compared to unconjugated oligomers has been studied in L929 cells. In parallel to their enhanced antiviral activity, PLL increases greatly the uptake of fluorescently tagged oligomers. This internalization follows a classical endocytic pathway and the oligomer has to be cleaved from PLL in the cell to exhibit an antiviral effect.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965625     DOI: 10.1021/bc00002a010

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  29 in total

1.  Delivery of oligonucleotides into mammalian cells by anionic peptides: comparison between monomeric and dimeric peptides.

Authors:  I Freulon; A C Roche; M Monsigny; R Mayer
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

2.  Peptides containing antigenic and cationic domains have enhanced, multivalent immunogenicity when bound to DNA vaccines.

Authors:  Petra Riedl; Jörg Reimann; Reinhold Schirmbeck
Journal:  J Mol Med (Berl)       Date:  2003-12-02       Impact factor: 4.599

3.  The vacuum UV CD spectra of G.G.C triplexes.

Authors:  K H Johnson; R H Durland; M E Hogan
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

4.  Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides.

Authors:  J A Hughes; A I Aronsohn; A V Avrutskaya; R L Juliano
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

Review 5.  Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.

Authors:  Johannes Winkler
Journal:  Ther Deliv       Date:  2011-07

6.  Radiolabeled oligonucleotides for antisense imaging.

Authors:  Arun K Iyer; Jiang He
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

7.  Dendritic alpha,epsilon-poly(L-lysine)s as delivery agents for antisense oligonucleotides.

Authors:  Khee Dong Eom; Sun Mi Park; Huu Dung Tran; Myong Soo Kim; Ri Na Yu; Hoon Yoo
Journal:  Pharm Res       Date:  2007-03-21       Impact factor: 4.200

8.  Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.

Authors:  Anna Karolina Kozlowska; Anna Florczak; Maciej Smialek; Ewelina Dondajewska; Andrzej Mackiewicz; Marcin Kortylewski; Hanna Dams-Kozlowska
Journal:  Acta Biomater       Date:  2017-07-08       Impact factor: 8.947

9.  Facile synthesis of multivalent folate-block copolymer conjugates via aqueous RAFT polymerization: targeted delivery of siRNA and subsequent gene suppression.

Authors:  Adam W York; Yilin Zhang; Andrew C Holley; Yanlin Guo; Faqing Huang; Charles L McCormick
Journal:  Biomacromolecules       Date:  2009-04-13       Impact factor: 6.988

10.  Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates.

Authors:  E Bonfils; C Depierreux; P Midoux; N T Thuong; M Monsigny; A C Roche
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.